MiNK Therapeutics Says First Patients In Randomized Phase 2 C-1300-02 Trial Of agenT-797 Alive At Day 28 With Improved Oxygenation, ARDS Resolution, Vasopressor Liberation
A drug company tested a new medicine on sick patients, and early signs show some patients improved with better breathing and needed less help from machines. When a medicine shows patients getting better in early testing, it's a good clue the company might be moving in the right direction, but there's lots more testing ahead before we know if it really works.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.